Tandem Diabetes Care Is Maintained at Buy by Truist Securities
Ratings actions from Benzinga: GMT) Tandem Diabetes Care Price Target Cut to $28.00/Share From $31.00 by Truist SecuritiesRatings actions from Benzinga
Ratings actions from Benzinga: GMT) Tandem Diabetes Care Price Target Cut to $28.00/Share From $31.00 by Truist SecuritiesRatings actions from Benzinga